Nonspecific reaction to cell mediated immunity measurement of gamma interferon antigen response without active tuberculosis
ICD-10 R76.12 is a billable code used to indicate a diagnosis of nonspecific reaction to cell mediated immunity measurement of gamma interferon antigen response without active tuberculosis.
R76.12 is used to classify a nonspecific reaction observed in patients undergoing cell-mediated immunity testing, specifically the gamma interferon release assay (IGRA), which is utilized to assess the immune response to specific tuberculosis antigens. This code indicates that while the test has shown a reaction, there is no evidence of active tuberculosis disease. Symptoms may include fatigue, malaise, or other nonspecific systemic symptoms, but these are not directly attributable to tuberculosis. The nonspecific nature of the reaction can arise from prior exposure to non-tuberculous mycobacteria, vaccination with the Bacillus Calmette-Guérin (BCG) vaccine, or other immune responses. Clinicians must interpret these results in conjunction with clinical findings and risk factors for tuberculosis exposure. The absence of active disease is crucial for accurate diagnosis and management, as it influences treatment decisions and public health reporting.
Detailed patient history, test results, and clinical correlation must be documented.
Patients presenting with respiratory symptoms and a positive IGRA test but no active TB.
Consideration of prior TB exposure and vaccination history is essential.
Acute care documentation must include the reason for testing and any immediate clinical findings.
Patients presenting with acute respiratory distress and a history of TB exposure.
Rapid assessment of symptoms and history is critical for accurate coding.
Used for screening patients at risk for tuberculosis.
Document the reason for the test and any relevant patient history.
Internal medicine and infectious disease specialists frequently order this test.
A positive IGRA test indicates that the patient has been exposed to tuberculosis antigens, but it does not confirm active tuberculosis disease. Further evaluation is necessary.
Document the patient's history, the reason for the test, the test results, and any clinical findings that support the diagnosis of R76.12.